Analysis of Low-dose High Resolution CT Imaging Features of Pulmonary Alveolar Proteinosis with Volumetric Data
1.Department of Radiology,the Affiliated Hospital of Southwest Medical University,Luzhou 646000,China
2.West China School of Public Health/Department of Radiology,West China Fourth Hospital,Sichuan University,Chengdu 610000,China
*Correspondent author:WEN Xiaoling,Attending physician;E-mail:mytestsohu@163.com
YANG Fan,XIAO Zhengyuan,WEN Xiaoling. Analysis of Low-dose High Resolution CT Imaging Features of Pulmonary Alveolar Proteinosis with Volumetric Data [J]. Chinese General Practice, 2020, 23(3): 353-357. DOI: 10.12114/j.issn.1007-9572.2019.00.524.
杨帆,肖正远,温晓玲. 肺泡蛋白沉积症低剂量容积数据高分辨率CT影像特征分析[J]. 中国全科医学, 2020, 23(3): 353-357. DOI: 10.12114/j.issn.1007-9572.2019.00.524.
[1]罗建光,杨东益,周顺科,等.肺泡蛋白沉积症所致铺路石征的CT表现及病理基础研究[J].中南大学学报:医学版,2014,39(9):924-929.
LUO J G,YANG D Y,ZHOU S K,et al.Crazy paving pattern caused by pulmonary alveolar proteinosis:CT findings and the pathologic basis[J].J Central South Univ:Med Sci,2014,39(9):924-929.
[2]陈露露,张艳秋,邱玉英,等.肺泡蛋白沉积症106例临床分析[J].南京医科大学学报:自然科学版,2018,38(6):804-806.
[3]李佩玲,刘屹,赵宇,等.肺泡蛋白沉积症的HRCT诊断[J].解剖科学进展,2016,22(1):39-41.DOI:10.16695/j.cnki.1006-2947.2016.01.012.
LI P L,LIU Y,ZHAO Y,et al.High resolution CT features of pulmonary alveolar proteinosis[J].Prog Anat Sci,2016,22(1):39-41.DOI:10.16695/j.cnki.1006-2947.2016.01.012.
[4]杜倩妮,宋伟,隋昕,等.肺泡蛋白沉积症的高分辨率CT定量分析及视觉评分与肺功能的相关性研究[J].中华放射学杂志,2018,52(4):267-271.
[5]KUMAR A,ABDELMALAK B,INOUE Y,et al.Pulmonary alveolar proteinosis in adults:pathophysiology and clinical approach[J].Lancet Respir Med,2018,6(7):554-565.DOI:10.1016/S2213-2600(18)30043-2.
[6]LETH S,BENDSTRUP E,VESTERGAARD H,et al.Autoimmune pulmonary alveolar proteinosis:treatment options in year 2013[J].Respirology,2013,18(1):82-91.DOI:10.1111/j.1440-1843.2012.02274.x.
[7]BEN-DOV I,SEGEL M J.Autoimmune pulmonary alveolar proteinosis:clinical course and diagnostic criteria[J].Autoimmun Rev,2014,13(4/5):513-517.DOI:10.1016/j.autrev.2014.01.046.
[8]张娟,杨小东,黄燕花,等.肺泡微结石症的研究进展[J].华西医学,2014,29(9):1775-1778.
[9]SUI X,DU Q N,XU K F,et al.Quantitative assessment of pulmonary alveolar proteinosis(PAP) with ultra-dose CT and correlation with pulmonary function tests(PFTs)[J].PLoS One,2017,12(3):e0172958.DOI:10.1371/journal.pone.0172958.
[10]周静珠,肖永龙,丁晶晶,等.肺泡蛋白沉积症患者血清中KL-6黏蛋白和白细胞介素13水平及其意义[J].中华结核和呼吸杂志,2015,38(2):110-114.
[11]TAZAWA R,INOUE Y,ARAI T,et al.Duration of benefit in patients with autoimmune pulmonary alveolar proteinosis after inhaled granulocyte-macrophage colony-stimulating factor therapy[J].Chest,2014,145(4):729-737.DOI:10.1378/chest.13-0603.
[12]周子青,郭文亮,陈愉,等.全肺灌洗术治疗肺泡蛋白沉积症围手术期并发症分析[J].中华结核和呼吸杂志,2017,40(7):499-503.
[13]ABDELMALAK B B,KHANNA A K,CULVER D A,et al.Therapeutic whole-lung lavage for pulmonary alveolar proteinosis:a procedural update[J].J Bronchology Interv Pulmonol,2015,22(3):251-258.DOI:10.1097/LBR.0000000000000180.
[14]OHKOUCHI S,AKASAKA K,ICHIWATA T,et al.Sequential granulocyte-macrophage colony-stimulating factor inhalation after whole-lung lavage for pulmonary alveolar proteinosis.A report of five intractable cases[J].Annals ATS,2017,14(8):1298-1304.DOI:10.1513/annalsats.201611-892bc.
[15]BERTELOOT L,TAAM R A,EMOND-GONSARD S,et al.Primary pulmonary alveolar proteinosis:computed tomography features at diagnosis[J].Pediatr Radiol,2014,44(7):795-802.DOI:10.1007/s00247-014-2888-1.
[16]TOKURA S,AKIRA M,OKUMA T,et al.A semiquantitative computed tomographic grading system for evaluating therapeutic response in pulmonary alveolar proteinosis[J].Ann Am Thorac Soc,2017,14(9):1403-1411.DOI:10.1513/AnnalsATS.201607-574OC.